•
Sep 30, 2021

Avidity Biosciences Q3 2021 Earnings Report

Total Revenue
$2.16M
Previous year: $1.75M
+23.9%
EPS
-$0.68
Previous year: -$0.31
+119.4%
Gross Profit
-$22.7M
Cash and Equivalents
$410M
Free Cash Flow
-$21.6M
Total Assets
$426M

Avidity Biosciences

Avidity Biosciences